U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Medical Devices
  3. Products and Medical Procedures
  4. Device Approvals and Clearances
  5. Recently-Approved Devices
  6. MYNX CONTROL Venous Vascular Closure Device (VCD) 6F-12F – P040044/S097
  1. Recently-Approved Devices

MYNX CONTROL Venous Vascular Closure Device (VCD) 6F-12F – P040044/S097

 

MYNX CONTROL Venous Vascular Closure Device with labeled components.


This is a brief overview of information related to FDA’s approval to market this product. See the links below to the Summary of Safety and Effectiveness Data (SSED) and product labeling for more complete information on this product, its indications for use, and the basis for FDA’s approval.

Product Name: MYNX CONTROL Venous Vascular Closure Device (VCD) 6F-12F
PMA Applicant: Cordis US Corporation
Address: 14201 NW 60th Ave., Miami Lakes, FL 33014
Approval Date: June 27, 2024
Approval Letter: Approval Order

What is it?

The MYNX CONTROL Venous Vascular Closure Device (VCD) is used to close puncture sites in the large veins of the leg (femoral vein) after a catheterization procedure. Catheterization procedures are used to study or treat a disease or condition in blood vessels or in the heart. The MYNX CONTROL Venous VCD includes gel and a long thin tube (delivery system). The delivery system places the gel into the blood vessel where the catheter was previously inserted.

Back to Top